About this trial
The primary aim of the Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Patient Registry is to conduct a prospectively-planned and efficient natural history study that will result in a more comprehensive understanding of the disease and its course and pace over time. Other registry objectives include the following:
* Provide a convenient online platform for participants (or caregivers) to self-report cases of PNH. * Develop a communications registry within the Global PNH Patient registry (e.g., to notify patients of research studies and clinical trials). * Characterize and describe the Global PNH population as a whole, enhancing the understanding of disease prevalence and phenotype as well as the rate of progression of disease characteristics. * Assist the PNH community with the development of recommendations and standards of care. * Be a case-finding resource to be used for researchers who seek to study the pathophysiology of PNH, retrospectively collate intervention outcomes, and design prospective trials of novel treatments.
Eligibility criteria
Qualifiers
legal adult participants who are able to provide their own consent;
children and adults unable to provide their own consent, for whom consent must be provided by a Legally Authorized Representative (LAR) who is a legal adult.
Individuals must have at least periodic access to the internet and be able to comply with web-based study procedures and data collections
Disqualifiers
Individuals not able to read and understand English.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Aplastic Anemia and MDS International Foundation
Lead sponsor
National Organization for Rare Disorders
Collaborator